medicare and glp-1 Drug Coverage Medicare Expands GLP-1 Medication Access

DOI: Published online: July 1, 2025 Division of Endocrinology and Metabolism, Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea Corresponding author: Hye Jin Yoo Division of Endocrinology and Metabolism, Department of Internal Medicine, Korea University Guro Hospital, Korea University College of Medicine, 148 Gurodong-ro, Guro-gu, Seoul 08308, Korea E-mail: [email protected] Copyright 2025 Korean Diabetes Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited

This Retatrutide Peptide Guide was created from the perspective of an experienced peptide supplier and educator who has supported researchers since 2003

University of Cambridge, United Kingdom (20)) were housed in plastic cages

The generic surge is expected to transform the market from one catering primarily to the affluent to one accessible by a much broader patient base, accelerating the GLP-1 market's growth from its current value to an estimated $1 billion+

In the same study, brain fog and/or reduced cognitive performance were reported by approximately 10% of adults during the ketogenic diet [74]

This raises concerns about whether marketing strategies are influencing prescribing practices more than clinical necessity